- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Colinz Laboratories has announced it is exempt from certain SEBI listing compliance rules, specifically those requiring disclosures about related party transactions. The company clarifies that under Regulation 15(2)(a) of the SEBI (LODR) Regulations, it is not obligated to submit these specific related party transaction reports. This means Colinz will not be filing such disclosures, streamlining its regulatory obligations in this particular area.